WallStreetZenWallStreetZen

NASDAQ: PRAX
Praxis Precision Medicines Inc Stock Ownership - Who owns Praxis Precision Medicines?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Praxis Precision Medicines Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Timothy Edwin KellyChief Financial Officer2025-05-14249$31.54
$7.85kBuy
Marcio SouzaChief Executive Officer2025-05-14348$31.54
$10.97kBuy
Lauren MastrocolaPrincipal Accounting Officer2025-02-1240$85.40
$3.42kSell
Alex NemiroffGeneral Counsel and Secretary2025-02-1251$85.40
$4.36kSell
Marcio SouzaChief Executive Officer2025-02-12401$85.40
$34.25kSell
Timothy Edwin KellyChief Financial Officer2025-01-12676$63.15
$42.69kSell
Lauren MastrocolaPrincipal Accounting Officer2025-01-12390$63.15
$24.63kSell
Alex NemiroffGeneral Counsel and Secretary2025-01-12579$63.15
$36.56kSell
Lauren MastrocolaPrincipal Accounting Officer2025-01-0735$77.52
$2.71kSell
Marcio SouzaChief Executive Officer2025-01-07434$77.52
$33.64kSell

1 of 2

PRAX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PRAX insiders and whales buy or sell their stock.

PRAX Shareholders

What type of owners hold Praxis Precision Medicines Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bsof Parallel Master Fund LP23.25%4,894,109$238.73MInsider
Stefan Vitorovic13.97%2,939,329$143.38MInsider
Janus Henderson Group PLC12.04%2,533,405$123.58MInstitution
Holdings A. Novo11.60%2,442,080$119.12MInsider
Adage Capital Management LP11.28%2,374,085$115.81MInsider
Adage Capital Partners GP LLC9.38%1,974,585$96.32MInstitution
Cormorant Asset Management LP7.72%1,625,000$79.27MInstitution
Blackrock Inc7.56%1,590,128$77.57MInstitution
Price T Rowe Associates Inc7.00%1,473,075$71.86MInstitution
Morgan Stanley5.83%1,226,339$59.82MInstitution

1 of 3

PRAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PRAX62.65%37.35%Net Selling
OCS9.14%0.00%
NUVB58.49%41.51%Net BuyingNet Buying
MLYS63.09%36.91%Net BuyingNet Selling
SYRE71.11%28.89%Net Selling
View Top Biotech Stocks

Praxis Precision Medicines Stock Ownership FAQ

Who owns Praxis Precision Medicines?

Praxis Precision Medicines (NASDAQ: PRAX) is owned by 114.74% institutional shareholders, 68.40% Praxis Precision Medicines insiders, and 0.00% retail investors. Bsof Parallel Master Fund LP is the largest individual Praxis Precision Medicines shareholder, owning 4.89M shares representing 23.25% of the company. Bsof Parallel Master Fund LP's Praxis Precision Medicines shares are currently valued at $229.73M.

If you're new to stock investing, here's how to buy Praxis Precision Medicines stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.